Standout Papers
Citation Impact
Citing Papers
Crystal Structure of a Lipid G Protein–Coupled Receptor
2012 Science
FTY720 (Fingolimod) Sensitizes Prostate Cancer Cells to Radiotherapy by Inhibition of Sphingosine Kinase-1
2010
Bifluoride Ion Mediated SuFEx Trifluoromethylation of Sulfonyl Fluorides and Iminosulfur Oxydifluorides
2019 StandoutNobel
Computational design of soluble and functional membrane protein analogues
2024 StandoutNatureNobel
Rethinking Chronic Allograft Nephropathy
1999
ACTIVATION OF MITOCHONDRIAL APOPTOTIC PATHWAYS IN HUMAN RENAL ALLOGRAFTS AFTER ISCHEMIA-REPERFUSION INJURY
2003
Delayed graft function in kidney transplantation
2004 Standout
The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates
1996 Standout
Pathophysiology of Progressive Nephropathies
1998 Standout
Chemokines and leukocyte traffic
1998 StandoutNature
X-Ray Structure of Acid-Sensing Ion Channel 1–Snake Toxin Complex Reveals Open State of a Na+-Selective Channel
2014 StandoutNobel
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
2010 Standout
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
2010 Standout
Modular click chemistry libraries for functional screens using a diazotizing reagent
2019 StandoutNatureNobel
A Nonsimultaneous, Extended, Altruistic-Donor Chain
2009 StandoutNobel
Acute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes
2014 Standout
Machine Perfusion Versus Cold Storage for the Preservation of Kidneys Donated After Cardiac Death
2010
Chemokines — Chemotactic Cytokines That Mediate Inflammation
1998 Standout
Blood pressure, stroke, and coronary heart disease *1Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias
1990 Standout
Delayed graft function of more than six days strongly decreases long-term survival of transplanted kidneys
1998
Genetic determinants of delayed graft function after kidney transplantation.
2002
A Clinical Trial of the Effects of Dietary Patterns on Blood Pressure
1997 Standout
PREDICTORS OF RENAL TRANSPLANT HISTOLOGY AT THREE MONTHS
1999
High-resolution crystal structure of human protease-activated receptor 1
2012 StandoutNatureNobel
Molecular Mechanisms of Human Hypertension
2001 Standout
Long-Term Morbidity and Mortality of Overweight Adolescents
1992 Standout
Beyond Cholesterol
1989 Standout
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
2004 StandoutNature
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
Opportunities and challenges in phenotypic drug discovery: an industry perspective
2017
The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
1996 StandoutNature
A prospective, randomized, clinical trial of intraoperative versus postoperative thymoglobulin in adult cadaveric renal transplant recipients1
2003
Perspectives in Organ Preservation
2007
Chemokines and renal disease
1995
Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study
2013
Obesity
2005 Standout
Sirolimus Prolongs Recovery from Delayed Graft Function After Cadaveric Renal Transplantation
2003
RANDOMIZED TRIAL OF TACROLIMUS PLUS MYCOPHENOLATE MOFETIL OR AZATHIOPRINE VERSUS CYCLOSPORINE ORAL SOLUTION (MODIFIED) PLUS MYCOPHENOLATE MOFETIL AFTER CADAVERIC KIDNEY TRANSPLANTATION: RESULTS AT 2 YEARS1
2001
The Natural History of Chronic Allograft Nephropathy
2003 Standout
Trimetazidine Reduces Renal Dysfunction by Limiting the Cold Ischemia/Reperfusion Injury in Autotransplanted Pig Kidneys
2000
Drug repurposing: progress, challenges and recommendations
2018 Standout
Abnormal Endothelium-Dependent Vascular Relaxation in Patients with Essential Hypertension
1990 Standout
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
2004 Standout
Multicenter Analysis of Kidney Preservation
2007
Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria
1995
Epidemiologic findings on body mass and blood pressure in adults
1991
The present and future role of microfluidics in biomedical research
2014 StandoutNature
Obesity and the Risk of Heart Failure
2002 Standout
Tackling the Shortage of Donor Kidneys: How to Use the Best that We Have
2003
Machine Perfusion or Cold Storage in Deceased-Donor Kidney Transplantation
2008 Standout
Strategies to Improve Long-Term Outcomes after Renal Transplantation
2002 Standout
FTY720: ALTERED LYMPHOCYTE TRAFFIC RESULTS IN ALLOGRAFT PROTECTION
2001
G protein-coupled receptors as therapeutic targets for multiple sclerosis
2012
Angiotensin II Type 1–Receptor Activating Antibodies in Renal-Allograft Rejection
2005 Standout
Avoidance of Cyclosporine in Renal Transplantation
2000
The renal allograft biopsy
1996
FTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation
2000
Assessment of renal graft function by perioperative monitoring of cortical microcirculation in kidney transplantation.1
2003
Cold Ischemia Time and Allograft Outcomes in Live Donor Renal Transplantation: Is Live Donor Organ Transport Feasible?
2006
Differential Expression of Heme Oxygenase-1 and Vascular Endothelial Growth Factor in Cadaveric and Living Donor Kidneys after Ischemia-Reperfusion
2003
Infection in Solid-Organ Transplant Recipients
2007 Standout
Impact of delayed function on long-term graft survival after solid organ transplantation
1999
Effects on Blood Pressure of Reduced Dietary Sodium and the Dietary Approaches to Stop Hypertension (DASH) Diet
2001 Standout
The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1
1996 StandoutNature
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
What's in the Pipeline? New Immunosuppressive Drugs in Transplantation
2002
Lysosome-targeting chimaeras for degradation of extracellular proteins
2020 StandoutNatureNobel
Ischemia-reperfusion injury in renal transplantation is independent of the immunologic background
2000
EFFECT OF HISTOLOGICAL DAMAGE ON LONG-TERM KIDNEY TRANSPLANT OUTCOME
2001
Development and Maintenance of Regulatory T cells
2013 StandoutNobel
Delayed graft function: a dilemma in renal transplantation
2005
Delayed graft function: risk factors and the relative effects of early function and acute rejection on long‐term survival in cadaveric renal transplantation
1999
Improved Graft Survival after Renal Transplantation in the United States, 1988 to 1996
2000 Standout
Modulation of neutrophil influx in glomerulonephritis in the rat with anti-macrophage inflammatory protein-2 (MIP-2) antibody.
1995
CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
1998 StandoutNature
The Many Roles of Chemokines and Chemokine Receptors in Inflammation
2006 Standout
Recovery from acute renal failure predisposes hypertension and secondary renal disease in response to elevated sodium
2007
Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines.
1994 Standout
Delayed graft function
2001
Blood pressure, dietary fats, and antioxidants
1988
The clinical and cost-effectiveness of pulsatile machine perfusion versus cold storage of kidneys for transplantation retrieved from heart-beating and non-heart-beating donors
2003
Serum calcium fractions in essential hypertensive and matched normotensive subjects.
1986
Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function
2001
Hypothesis: Is renal allograft rejection initiated by the response to injury sustained during the transplant process?
1999
Prediction of Coronary Heart Disease Using Risk Factor Categories
1998 Standout
Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14.
1993
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein.
1997
Sweeping antibody as a novel therapeutic antibody modality capable of eliminating soluble antigens from circulation
2016
Beneficial effects of treatment of early subclinical rejection
1998
CHEMOKINES, SPHINGOSINE-1-PHOSPHATE, AND CELL MIGRATION IN SECONDARY LYMPHOID ORGANS
2004
Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists
2002 StandoutScience
1997 StandoutNobel
A Biophysical Indicator of Vaso-occlusive Risk in Sickle Cell Disease
2012
Fingolimod (FTY720): A Recently Approved Multiple Sclerosis Drug Based on a Fungal Secondary Metabolite
2011
Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry
1993
A Common Dominant TLR5 Stop Codon Polymorphism Abolishes Flagellin Signaling and Is Associated with Susceptibility to Legionnaires' Disease
2003 StandoutNobel
Delayed graft function. Influence on outcome and strategies for prevention.
2001
The relative contribution of body fat and fat pattern to blood pressure level.
1985
Delayed graft function in renal transplantation
2004
Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010
2012 Standout
Immunomodulatory drug FTY720 induces regulatory CD4+CD25+ T cellsin vitro
2009
Discovery of BAF312 (Siponimod), a Potent and Selective S1P Receptor Modulator
2013
Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
1988 Standout
Bacterial Lipopolysaccharide Induces Transforming Growth Factor β and Hepatocyte Growth Factor through Tolllike Receptor 2 in Cultured Human Colon Cancer Cells
2001
Alternative pathway activation of complement by cultured human proximal tubular epithelial cells
1994
Works of Robert Schmouder being referenced
DELAYED GRAFT FUNCTION: RISK FACTORS AND IMPLICATIONS FOR RENAL ALLOGRAFT SURVIVAL1
1997 Standout
First Human Trial of FTY720, a Novel Immunomodulator, in Stable Renal Transplant Patients
2002
A randomized controlled trial with an anti‐CCL2 (anti–monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis
2006
Oral‐intravenous crossover study of fingolimod pharmacokinetics, lymphocyte responses and cardiac effects
2007
PROGNOSIS AFTER PRIMARY RENAL TRANSPLANT FAILURE AND THE BENEFICIAL EFFECTS OF REPEAT TRANSPLANTATION
1998
FTY720: Placebo‐Controlled Study of the Effect on Cardiac Rate and Rhythm in Healthy Subjects
2006
Pharmacodynamics of Single Doses of the Novel Immunosuppressant FTY720 in Stable Renal Transplant Patients
2003
In vitro and in vivo interleukin-8 production in human renal cortical epithelia
1992
Multiple‐Dose FTY720: Tolerability, Pharmacokinetics, and Lymphocyte Responses in Healthy Subjects
2004
FTY720, a Novel Immunomodulator in de Novo Kidney Transplant Patients: Pharmacokinetics and Exposure‐Response Relationship
2005
Interferon-γ regulation of human renal cortical epithelial cell-derived monocyte chemotactic peptide-1
1993
Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: a multicenter, randomized, placebo-controlled, phase I study
2003
Overview of FTY720 Clinical Pharmacokinetics and Pharmacology
2004
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
2010
Next-generation biomarkers for detecting kidney toxicity
2010
FTY 720A mediates reduction of lymphocyte counts in human renal allograft recipients by an apoptosis-independent mechanism
2000
BLOOD PRESSURE AND NUTRITION IN ADULTS THE NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY1
1984
FTV 720A mediates reduction of lymphocyte counts in human renal allograft recipients by an apoptosis-independent mechanism
2000
HUMAN SAFETY AND PHARMACOLOGY OF FTY 720
1999
HUMAN PHARMACOKINETICS OF FTY 720
1999
SAFETY AND PHARMACODYNAMICS OF MULTIPLE DOSES OF FTY720.
2000